FDA Inspection 1196024 — Secura Bio, Inc
The FDA completed an inspection of Secura Bio, Inc on Jan 17, 2023 in Berkeley Heights, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Jan 17, 2023
- Fiscal Year
- 2023
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Berkeley Heights, NJ (United States)
Additional Details
Postmarket Adverse Drug Experience (PADE)